Express Pharma

JUNE 3, 2024

mRESVIA is Moderna’s second approved product and reportedly the only RSV vaccine available in single-dose pre-filled syringes Moderna, announced that the U.S. This approval is also the first time an mRNA vaccine has been approved for a disease other than COVID-19. The primary analysis with 3.7 per cent (95.88 per cent CI 66.0

Vaccines 81

Vaccines Adverse Reactions Packaging 81

Pharmaceutical Business Review

SEPTEMBER 2, 2024

The Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) [NVX-CoV2705] is now authorised for active immunisation against Covid-19. Following the EUA, the vaccine is also recommended by the US Centers for Disease Control and Prevention (CDC). Our updated vaccine targets JN.1, 1.” “Our updated vaccine targets JN.1,

Vaccines 59

Vaccines Adverse Reactions Immunity Immunization 59

European Pharmaceutical Review

NOVEMBER 10, 2023

The US Food and Drug Administration (FDA) has approved Valneva SE’s IXCHIQ ® , the first chikungunya vaccine to be authorised in the world. The single-dose, live-attenuated vaccine is indicated for preventing chikungunya virus disease in individuals over 18 years old who are at increased risk of contracting the virus.

Vaccines 52

Vaccines Adverse Reactions Immunity Immunization 52

FDA Law Blog: Biosimilars

APRIL 7, 2025

Elanco is the manufacturer of recently approved Zenrelia (ilunocitinib tablets) (September 2024), which is indicated for control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age. Further, information presented on the adverse reaction data was inconsistent with the PI.

Vaccines 64

Vaccines Adverse Reactions 64

Amber

SEPTEMBER 12, 2024

12, 2024) – Amber Specialty Pharmacy, a leader in the specialty pharmacy industry, is excited to announce the availability of Galderma’s latest medication, NEMLUVIO® (nemolizumab-ilto), for the treatment of Prurigo Nodularis in adults. Avoid use of live vaccines during treatment with NEMLUVIO. Omaha, Neb.

Specialty Pharmacies 52

Specialty Pharmacies Adverse Reactions Customer Service Vaccines 52

Express Pharma

APRIL 1, 2025

Pfizer announced that the European Commission (EC) has amended the marketing authorisation for ABRYSVO, the companys bivalent respiratory syncytial virus (RSV) prefusion F (RSVpreF) vaccine, to include the prevention of lower respiratory tract disease (LRTD) caused by RSV in individuals aged 18 to 59.

Adverse Reactions 66

Adverse Reactions Vaccines Immunity Immunization 66